These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Survival prognostic factors and markers of morbidity in Spanish patients with systemic sclerosis. Simeon CP; Armadans L; Fonollosa V; Vilardell M; Candell J; Tolosa C; Mearin F; Rodrigo MJ; Solans R; Lima J; Sampol G Ann Rheum Dis; 1997 Dec; 56(12):723-8. PubMed ID: 9496151 [TBL] [Abstract][Full Text] [Related]
5. Clinical approach to scleroderma. White B Semin Cutan Med Surg; 1998 Sep; 17(3):213-8. PubMed ID: 9759679 [TBL] [Abstract][Full Text] [Related]
6. Sine scleroderma, limited cutaneous, and diffused cutaneous systemic sclerosis survival and predictors of mortality. De Almeida Chaves S; Porel T; Mounié M; Alric L; Astudillo L; Huart A; Lairez O; Michaud M; Prévot G; Ribes D; Sailler L; Gaches F; Adoue D; Pugnet G Arthritis Res Ther; 2021 Dec; 23(1):295. PubMed ID: 34876194 [TBL] [Abstract][Full Text] [Related]
7. Determinants of morbidity and mortality of systemic sclerosis in Canada. Al-Dhaher FF; Pope JE; Ouimet JM Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680 [TBL] [Abstract][Full Text] [Related]
8. Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry. Tolosa-Vilella C; Morera-Morales ML; Simeón-Aznar CP; Marí-Alfonso B; Colunga-Arguelles D; Callejas Rubio JL; Rubio-Rivas M; Freire-Dapena M; Guillén-Del Castillo A; Iniesta-Arandia N; Castillo-Palma MJ; Egurbide-Arberas M; Trapiellla-Martínez L; Vargas-Hitos JA; Todolí-Parra JA; Rodriguez-Carballeira M; Marin-Ballvé A; Pla-Salas X; Rios-Blanco JJ; Fonollosa-Pla V; Semin Arthritis Rheum; 2016 Oct; 46(2):200-208. PubMed ID: 27312381 [TBL] [Abstract][Full Text] [Related]
9. Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group. Sánchez-Cano D; Ortego-Centeno N; Callejas JL; Fonollosa Plá V; Ríos-Fernández R; Tolosa-Vilella C; Espinosa-Garriga G; Colunga-Argüelles D; Egurbide-Arberas MV; Rubio-Rivas M; Freire M; Ríos-Blanco JJ; Trapiella-Martínez L; Rodríguez-Carballeira M; Marín-Ballvé A; Pla-Salas X; Simeón-Aznar CP Rheumatol Int; 2018 Mar; 38(3):363-374. PubMed ID: 29322341 [TBL] [Abstract][Full Text] [Related]
10. The heart and pulmonary arterial hypertension in systemic sclerosis. Vandecasteele EH; De Pauw M; Brusselle G; Decuman S; Piette Y; De Keyser F; Smith V Acta Clin Belg; 2016 Feb; 71(1):1-18. PubMed ID: 27075793 [TBL] [Abstract][Full Text] [Related]
11. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis. Hamaguchi Y J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839 [TBL] [Abstract][Full Text] [Related]
12. Systemic sclerosis sine scleroderma and limited cutaneous systemic sclerosis: similarities and differences. Simeón-Aznar CP; Tolosa-Vilella C; Gabarró-Juliá L; Campillo-Grau M; Guillén Del Castillo A; Fonollosa-Plá V; Vilardell-Tarrés M Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-33-40. PubMed ID: 24776173 [TBL] [Abstract][Full Text] [Related]
13. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status. Simeón-Aznar CP; Fonollosa-Plá V; Tolosa-Vilella C; Espinosa-Garriga G; Ramos-Casals M; Campillo-Grau M; García-Hernández FJ; Castillo-Palma MJ; Sánchez-Román J; Callejas-Rubio JL; Ortego-Centeno N; Egurbide-Arberas MV; Trapiellla-Martínez L; Gallego-Villalobos M; Sáez-Comet L; Velilla-Marco J; Camps-García MT; de Ramón-Garrido E; Esteban Marcos EM; Pallarés-Ferreres L; Hidalgo-Tenorio C; Sabio-Sánchez JM; Gómez-de la Torre R; Salvador-Cervello G; Rios-Blanco JJ; Gil-Aguado A; Vilardell-Tarrés M Semin Arthritis Rheum; 2012 Jun; 41(6):789-800. PubMed ID: 22169458 [TBL] [Abstract][Full Text] [Related]
14. Isolated pulmonary hypertension in systemic sclerosis with diffuse cutaneous involvement: association with serum anti-U3RNP antibody. Sacks DG; Okano Y; Steen VD; Curtiss E; Shapiro LS; Medsger TA J Rheumatol; 1996 Apr; 23(4):639-42. PubMed ID: 8730118 [TBL] [Abstract][Full Text] [Related]
15. Pulmonary involvement in systemic sclerosis. Shahin AA Treat Respir Med; 2006; 5(6):429-36. PubMed ID: 17154672 [TBL] [Abstract][Full Text] [Related]
16. Lung transplantation in patients with scleroderma. De Cruz S; Ross D Curr Opin Rheumatol; 2013 Nov; 25(6):714-8. PubMed ID: 24061075 [TBL] [Abstract][Full Text] [Related]
17. Thinking outside the box--The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect. Srivastava N; Hudson M; Tatibouet S; Wang M; Baron M; Fritzler MJ; Semin Arthritis Rheum; 2015 Oct; 45(2):184-9. PubMed ID: 25959492 [TBL] [Abstract][Full Text] [Related]
18. Nailfold capillaroscopy abnormalities correlate with cutaneous and visceral involvement in systemic sclerosis patients. Sato LT; Kayser C; Andrade LE Acta Reumatol Port; 2009; 34(2A):219-27. PubMed ID: 19474777 [TBL] [Abstract][Full Text] [Related]
19. Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease. Chauvelot L; Gamondes D; Berthiller J; Nieves A; Renard S; Catella-Chatron J; Ahmad K; Bertoletti L; Camara B; Gomez E; Launay D; Montani D; Mornex JF; Prévot G; Sanchez O; Schott AM; Subtil F; Traclet J; Turquier S; Zeghmar S; Habib G; Reynaud-Gaubert M; Humbert M; Cottin V Arthritis Rheumatol; 2021 Feb; 73(2):295-304. PubMed ID: 32892515 [TBL] [Abstract][Full Text] [Related]
20. Mortality in the Waikato Hospital Systemic Sclerosis Cohort. Ooi C; Solanki K; Lao C; Frampton C; White D Int J Rheum Dis; 2018 Jan; 21(1):253-260. PubMed ID: 28580628 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]